[go: up one dir, main page]

AU7274198A - Antithrombotic agents - Google Patents

Antithrombotic agents

Info

Publication number
AU7274198A
AU7274198A AU72741/98A AU7274198A AU7274198A AU 7274198 A AU7274198 A AU 7274198A AU 72741/98 A AU72741/98 A AU 72741/98A AU 7274198 A AU7274198 A AU 7274198A AU 7274198 A AU7274198 A AU 7274198A
Authority
AU
Australia
Prior art keywords
formula
antithrombotic agents
novel compounds
compounds
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72741/98A
Inventor
Nickolay Yuri Chirgadze
Matthew Joseph Fisher
Richard Waltz Harper
Ho-Shen Lin
Jefferson Ray Mccowan
Alan David Palkowitz
Michael Enrico Richett
Daniel Jon Sall
Gerald Floyd Smith
Kumiko Takeuchi
Minsheng Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU7274198A publication Critical patent/AU7274198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This application relates to novel compounds of formula (I) (and their pharmaceutically acceptable salts), as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula (I), and the use of the compounds of formula (I) as thrombin inhibitors.
AU72741/98A 1997-04-30 1998-04-30 Antithrombotic agents Abandoned AU7274198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4429697P 1997-04-30 1997-04-30
US60044296 1997-04-30
PCT/US1998/008831 WO1998049160A1 (en) 1997-04-30 1998-04-30 Antithrombotic agents

Publications (1)

Publication Number Publication Date
AU7274198A true AU7274198A (en) 1998-11-24

Family

ID=21931578

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72741/98A Abandoned AU7274198A (en) 1997-04-30 1998-04-30 Antithrombotic agents

Country Status (9)

Country Link
US (1) US6271227B1 (en)
EP (1) EP0980366B1 (en)
JP (1) JP2001522373A (en)
AT (1) ATE268768T1 (en)
AU (1) AU7274198A (en)
CA (1) CA2287982A1 (en)
DE (1) DE69824410T2 (en)
ES (1) ES2223129T3 (en)
WO (1) WO1998049160A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE263164T1 (en) * 1997-10-03 2004-04-15 Lilly Co Eli BENZOTHIOPHENE

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274213A (en) 1961-09-05 1966-09-20 Upjohn Co Alkoxy-substituted 2-phenyl-1-(tertiary-aminoalkoxy)phenyl-3, 4-dihydronaphthalenes
US3293263A (en) 1963-12-09 1966-12-20 Upjohn Co Diphenylbenzocycloalkenes
GB1456323A (en) 1974-06-06 1976-11-24 Labaz Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
US4001426A (en) 1974-10-17 1977-01-04 Smithkline Corporation Substituted benzofurans and benzothiophenes
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
ZA928276B (en) 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
JP3157882B2 (en) 1991-11-15 2001-04-16 帝国臓器製薬株式会社 New benzothiophene derivatives
US5482949A (en) 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
AU1440395A (en) 1993-12-21 1995-07-10 Eli Lilly And Company Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
EP0736007A4 (en) 1993-12-21 1997-03-19 Lilly Co Eli Non-peptide tachykinin receptor antagonists
US5441965A (en) 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
IL115582A0 (en) 1994-10-14 1996-01-19 Lilly Co Eli Methods for treating resistant tumors
US5589482A (en) * 1994-12-14 1996-12-31 Pfizer Inc. Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
US5552401A (en) * 1995-02-28 1996-09-03 Eli Lilly And Company 2-benzyl-3-arylbenzothiophenes
US5510357A (en) 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
US5523309A (en) 1995-03-10 1996-06-04 Eli Lilly And Company Benzofuran pharmaceutical compounds
US5567828A (en) 1995-06-07 1996-10-22 Eli Lilly And Company Compounds and compositions with nitrogen-containing non-basic side
US5532254A (en) 1995-06-07 1996-07-02 Eli Lilly And Company Modulation of calcium channels using benzothiophenes
DE69634045T2 (en) * 1995-10-31 2005-05-19 Eli Lilly And Co., Indianapolis ANTITHROMBOTIC DIAMINE

Also Published As

Publication number Publication date
US6271227B1 (en) 2001-08-07
WO1998049160A1 (en) 1998-11-05
ATE268768T1 (en) 2004-06-15
JP2001522373A (en) 2001-11-13
DE69824410T2 (en) 2005-06-02
EP0980366A1 (en) 2000-02-23
EP0980366A4 (en) 2000-05-17
DE69824410D1 (en) 2004-07-15
CA2287982A1 (en) 1998-11-05
EP0980366B1 (en) 2004-06-09
ES2223129T3 (en) 2005-02-16

Similar Documents

Publication Publication Date Title
IL133623A0 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
AU7725596A (en) Antithrombotic diamines
AU2054700A (en) Antithrombotic amides
AU2055500A (en) Aromatic amides
AU2364600A (en) Heteroroaromatic amides as inhibitor of factor xa
YU57600A (en) Bicyclic hydroxamic acid derivatives
SE9504661D0 (en) New compounds
GB9914486D0 (en) Medicaments
AU3850600A (en) Dalda analogs and their use
AU7270798A (en) Antithrombotic agents
CA2219359A1 (en) Hydantoin derivatives as intermediates for pharmaceutical active compounds
AU2001282871A1 (en) Antithrombotic agents
AU7470098A (en) Antithrombotic agents
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
AU1767297A (en) Benzo(C)quinolizine derivatives, their preparation and use as 5alpha-reductases inhibitors
AU5390900A (en) Potassium channel blocking agents
SE9504662D0 (en) New compounds
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
DE69927997D1 (en) Novel pyrimidine derivatives and method for their preparation
AU1434201A (en) Antithrombotic agents
AU7274198A (en) Antithrombotic agents
TR199900013T2 (en) New bracelets.
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
DE69914563D1 (en) Azaindole derivatives and their use as antithrombotic agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase